Natural Products as Sources of New Drugs from 1981 to 2014
- PMID: 26852623
- DOI: 10.1021/acs.jnatprod.5b01055
Natural Products as Sources of New Drugs from 1981 to 2014
Abstract
This contribution is a completely updated and expanded version of the four prior analogous reviews that were published in this journal in 1997, 2003, 2007, and 2012. In the case of all approved therapeutic agents, the time frame has been extended to cover the 34 years from January 1, 1981, to December 31, 2014, for all diseases worldwide, and from 1950 (earliest so far identified) to December 2014 for all approved antitumor drugs worldwide. As mentioned in the 2012 review, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions and the designation "natural product botanical", or "NB", to cover those botanical "defined mixtures" now recognized as drug entities by the U.S. FDA (and similar organizations). From the data presented in this review, the utilization of natural products and/or their novel structures, in order to discover and develop the final drug entity, is still alive and well. For example, in the area of cancer, over the time frame from around the 1940s to the end of 2014, of the 175 small molecules approved, 131, or 75%, are other than "S" (synthetic), with 85, or 49%, actually being either natural products or directly derived therefrom. In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore it is considered that this area of natural product research should be expanded significantly.
Similar articles
-
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.J Nat Prod. 2020 Mar 27;83(3):770-803. doi: 10.1021/acs.jnatprod.9b01285. Epub 2020 Mar 12. J Nat Prod. 2020. PMID: 32162523 Review.
-
Natural products as sources of new drugs over the 30 years from 1981 to 2010.J Nat Prod. 2012 Mar 23;75(3):311-35. doi: 10.1021/np200906s. Epub 2012 Feb 8. J Nat Prod. 2012. PMID: 22316239 Free PMC article. Review.
-
Natural products as sources of new drugs over the last 25 years.J Nat Prod. 2007 Mar;70(3):461-77. doi: 10.1021/np068054v. Epub 2007 Feb 20. J Nat Prod. 2007. PMID: 17309302 Review.
-
Natural products as sources of new drugs over the period 1981-2002.J Nat Prod. 2003 Jul;66(7):1022-37. doi: 10.1021/np030096l. J Nat Prod. 2003. PMID: 12880330 Review.
-
Natural product scaffolds as leads to drugs.Future Med Chem. 2009 Nov;1(8):1415-27. doi: 10.4155/fmc.09.113. Future Med Chem. 2009. PMID: 21426057 Review.
Cited by
-
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning.Comput Biol Med. 2021 Jun;133:104359. doi: 10.1016/j.compbiomed.2021.104359. Epub 2021 Mar 30. Comput Biol Med. 2021. PMID: 33845270 Free PMC article.
-
Mediterranean Shrub Species as a Source of Biomolecules against Neurodegenerative Diseases.Molecules. 2023 Dec 16;28(24):8133. doi: 10.3390/molecules28248133. Molecules. 2023. PMID: 38138621 Free PMC article. Review.
-
Antioxidant, antibacterial, and molecular docking of methyl ferulate and oleic acid produced by Aspergillus pseudodeflectus AUMC 15761 utilizing wheat bran.Sci Rep. 2024 Feb 7;14(1):3183. doi: 10.1038/s41598-024-52045-z. Sci Rep. 2024. PMID: 38326360 Free PMC article.
-
Identification of a Prenyl Chalcone as a Competitive Lipoxygenase Inhibitor: Screening, Biochemical Evaluation and Molecular Modeling Studies.Molecules. 2021 Apr 12;26(8):2205. doi: 10.3390/molecules26082205. Molecules. 2021. PMID: 33921198 Free PMC article.
-
Chitosan/hesperidin nanoparticles formulation: a promising approach against ethanol-induced gastric ulcers via Sirt1/FOXO1/PGC-1α/HO-1 pathway.Front Pharmacol. 2024 Sep 9;15:1433793. doi: 10.3389/fphar.2024.1433793. eCollection 2024. Front Pharmacol. 2024. PMID: 39314751 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials